Sandra Barral
Columbia University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sandra Barral.
Nature Genetics | 2005
Orna Levran; Claire Attwooll; Rashida Henry; Kelly Milton; Kornelia Neveling; Paula Río; Sat Dev Batish; Reinhard Kalb; Eunike Velleuer; Sandra Barral; Jurg Ott; John H.J. Petrini; Detlev Schindler; Helmut Hanenberg; Arleen D. Auerbach
Seven Fanconi anemia–associated proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG and FANCL) form a nuclear Fanconi anemia core complex that activates the monoubiquitination of FANCD2, targeting FANCD2 to BRCA1-containing nuclear foci. Cells from individuals with Fanconi anemia of complementation groups D1 and J (FA-D1 and FA-J) have normal FANCD2 ubiquitination. Using genetic mapping, mutation identification and western-blot data, we identify the defective protein in FA-J cells as BRIP1 (also called BACH1), a DNA helicase that is a binding partner of the breast cancer tumor suppressor BRCA1.
JAMA Neurology | 2011
Joseph H. Lee; Rong Cheng; Sandra Barral; Christiane Reitz; Martin Medrano; Rafael Lantigua; Ivonne Z. Jimenez-Velazquez; Ekaterina Rogaeva; Peter St George-Hyslop; Richard Mayeux
OBJECTIVES To identify novel loci for late-onset Alzheimer disease (LOAD) in Caribbean Hispanic individuals and to replicate the findings in a publicly available data set from the National Institute on Aging Late-Onset Alzheimers Disease Family Study. DESIGN Nested case-control genome-wide association study. SETTING The Washington Heights-Inwood Columbia Aging Project and the Estudio Familiar de Influencia Genetica de Alzheimer study. PARTICIPANTS Five hundred forty-nine affected and 544 unaffected individuals of Caribbean Hispanic ancestry. INTERVENTION The Illumina HumanHap 650Y chip for genotyping. MAIN OUTCOME MEASURE Clinical diagnosis or pathologically confirmed diagnosis of LOAD. RESULTS The strongest support for allelic association was for rs9945493 on 18q23 (P=1.7×10(-7)), but 22 additional single-nucleotide polymorphisms (SNPs) had a P value less than 9×10(-6) under 3 different analyses: unadjusted and stratified by the presence or absence of the APOE ε4 allele. Of these SNPs, 5 SNPs (rs4669573 and rs10197851 on 2p25.1; rs11711889 on 3q25.2; rs1117750 on 7p21.1; and rs7908652 on 10q23.1) were associated with LOAD in an independent cohort from the National Institute on Aging Late-Onset Alzheimers Disease Family Study. We also replicated genetic associations for CLU, PICALM, and BIN1. CONCLUSIONS Our genome-wide search of Caribbean Hispanic individuals identified several novel genetic variants associated with LOAD and replicated these associations in a white cohort. We also replicated associations in CLU, PICALM, and BIN1 in the Caribbean Hispanic cohort.
Pain | 2005
Noora Noponen-Hietala; Iita M Virtanen; Riitta Karttunen; Susanne Schwenke; Eveliina Jakkula; Hong Li; Riitta Merikivi; Sandra Barral; Jurg Ott; Jaro Karppinen; Leena Ala-Kokko
&NA; Intervertebral disc disease (IDD) characterized by sciatica is a common disorder affecting about 5% of individuals. Environmental factors can predispose to this disease, but IDD has a strong genetic background. Recent evidence suggests that inflammation is one of the key factors in the etiology of IDD. Here, a possible role of the inflammatory mediator genes was studied in 155 patients with IDD‐related sciatica and 179 controls. Forty‐eight patients were analyzed for mutations in the IL1A, IL1B, IL6 and TNFA genes, and 16 polymorphisms in 10 candidate cytokine genes (IL1A, IL1B, IL1RN, TNFA, IL2, IL4, IL4R, IL6, IL10, IFNG) were genotyped from all subjects. No disease‐causing mutations were identified in IL1A, IL1B, IL6 or TNFA. Allele frequencies were, however, significantly different between the two groups for IL6 SNP, T15A in exon 5 (P=0.007). Furthermore, the genotypes AA and AT of the exon 5 SNP were more common in the patients (P=0.011; OR=4.4, 95% CI=1.2–15.7; AR=7.5%, 1.6–13.1%). Haplotypes were then generated for four IL6 SNPs, G‐597A, G‐572C, G‐174C, and T15A in exon 5. Haplotype GGGA was more common in the patients (P=0.011; OR=4.8, 95% CI=1.6–14.5). To evaluate attributable risk, haplotype pairs were assigned for the individuals. The presence of GGGA/GGGA or GGGA/other genotypes had an OR of 5.4 (95% CI=1.5–19.2). Association of GGGA with disease was highly significant (P=0.0033), and the associated AR was 6.8% (1.9–11.5%). These findings support the role of IL‐6 genetic variations in discogenic pain.
American Journal of Human Genetics | 2008
Catarina M. Quinzii; Tuan Vu; K. Christopher Min; Kurenai Tanji; Sandra Barral; Raji P. Grewal; Andrea Kattah; Pilir Camaño; David Otaegui; Teruhito Kunimatsu; David M. Blake; Kirk C. Wilhelmsen; Lewis P. Rowland; Arthur P. Hays; Eduardo Bonilla; Michio Hirano
Scapuloperoneal (SP) syndrome encompasses heterogeneous neuromuscular disorders characterized by weakness in the shoulder-girdle and peroneal muscles. In a large Italian-American pedigree with dominant SP myopathy (SPM) previously linked to chromosome 12q, we have mapped the disease to Xq26, and, in all of the affected individuals, we identified a missense change (c.365G-->C) in the FHL1 gene encoding four-and-a-half-LIM protein 1 (FHL1). The mutation substitutes a serine for a conserved trypophan at amino acid 122 in the second LIM domain of the protein. Western blot analyses of muscle extracts revealed FHL1 loss that paralleled disease severity. FHL1 and an isoform, FHL1C, are highly expressed in skeletal muscle and may contribute to stability of sarcomeres and sarcolemma, myofibrillary assembly, and transcriptional regulation. This is the first report, to our knowledge, of X-linked dominant SP myopathy and the first human mutation in FHL1.
Clinical Cancer Research | 2008
Yu-Wei Cheng; Hanna Pincas; Manny D. Bacolod; Gunter S. Schemmann; Sarah F. Giardina; Jianmin Huang; Sandra Barral; Kamran Idrees; Sajid A. Khan; Zhaoshi Zeng; Shoshana Rosenberg; Daniel A. Notterman; Jurg Ott; Philip B. Paty; Francis Barany
Purpose: Aberrant promoter methylation and genomic instability occur frequently during colorectal cancer development. CpG island methylator phenotype (CIMP) has been shown to associate with microsatellite instability, and BRAF mutation and is often found in the right-side colon. Nevertheless, the relative importance of CIMP and chromosomal instability (CIN) for tumorigenesis has yet to be thoroughly investigated in sporadic colorectal cancers. Experimental Design: We determined CIMP in 161 primary colorectal cancers and 66 matched normal mucosae using a quantitative bisulfite/PCR/ligase detection reaction (LDR)/Universal Array assay. The validity of CIMP was confirmed in a subset of 60 primary tumors using MethyLight assay and five independent markers. In parallel, CIN was analyzed in the same study cohort using Affymetrix 50K Human Mapping arrays. Results: The identified CIMP-positive cancers correlate with microsatellite instability (P = 0.075) and the BRAF mutation V600E (P = 0.00005). The array-based high-resolution analysis of chromosomal aberrations indicated that the degree of aneuploidy is spread over a wide spectrum among analyzed colorectal cancers. Whether CIN was defined by copy number variations in selected microsatellite loci (criterion 1) or considered as a continuous variable (criterion 2), CIMP-positive samples showed a strong correlation with low-degree chromosomal aberrations (P = 0.075 and P = 0.012, respectively). Similar correlations were observed when CIMP was determined by MethyLight assay (P = 0.001 and P = 0.013, respectively). Conclusion: CIMP-positive tumors generally possess lower chromosomal aberrations, which may only be revealed using a genome-wide approach. The significant difference in the degree of chromosomal aberrations between CIMP-positive and the remainder of samples suggests that epigenetic (CIMP) and genetic (CIN) abnormalities may arise from independent molecular mechanisms of tumor progression.
Spine | 2007
Iita M Virtanen; Jaro Karppinen; Simo Taimela; Jurg Ott; Sandra Barral; Kaisu Kaikkonen; Olli Heikkilä; Pertti Mutanen; Noora Noponen; Minna Männikkö; Osmo Tervonen; Antero Natri; Leena Ala-Kokko
Study Design. Cross-sectional epidemiologic study. Objective. To evaluate the interaction between known genetic risk factors and whole-body vibration for symptomatic intervertebral disc disease (IDD) in an occupational sample. Summary of Background Data. Risk factors of IDD include, among others, whole-body vibration and heredity. In this study, the importance of a set of known genetic risk factors and whole-body vibration was evaluated in an occupational sample of train engineers and sedentary controls. Methods. Eleven variations in 8 genes (COL9A2, COL9A3, COL11A2, IL1A, IL1B, IL6, MMP-3, and VDR) were genotyped in 150 male train engineers with an average of 21-year exposure to whole-body vibration and 61 male paper mill workers with no exposure to vibration. Subjects were classified into IDD-phenotype and asymptomatic groups, based on the latent class analysis. Results. The number of individuals belonging to the IDD-phenotype was significantly higher among train engineers (42% of train engineers vs. 17.5% of sedentary workers; P = 0.005). IL1A −889T allele represented a significant risk factor for the IDD-phenotype both in the single marker allelic association test (P = 0.043) and in the logistic regression analysis (P = 0.01). None of the other allele markers was significantly associated with symptoms when analyzed independently. However, for all the SNP markers considered, whole-body vibration represents a nominally significant risk factor. Conclusion. The results suggest that whole-body vibration is a risk factor for symptomatic IDD. Moreover, whole-body vibration had an additive effect with genetic risk factors increasing the likelihood of belonging to the IDD-phenotype group. Of the independent genetic markers, IL1A −889T allele had strongest association with IDD-phenotype.
Annals of Neurology | 2015
Badri N. Vardarajan; Mahdi Ghani; Amanda Kahn; Stephanie Sheikh; Christine Sato; Sandra Barral; Joseph H. Lee; Rong Cheng; Christiane Reitz; Rafael Lantigua; Dolly Reyes-Dumeyer; Martin Medrano; Ivonne Z. Jimenez-Velazquez; Ekaterina Rogaeva; Peter St George-Hyslop; Richard Mayeux
To detect rare coding variants underlying loci detected by genome‐wide association studies (GWAS) of late onset Alzheimer disease (LOAD).
Annals of Neurology | 2015
Badri N. Vardarajan; Mahdi Ghani; Amanda Kahn; Stephanie Sheikh; Christine Sato; Sandra Barral; Joseph H. Lee; Rong Cheng; Christiane Reitz; Rafael Lantigua; Dolly Reyes-Dumeyer; Martin Medrano; Ivonne Z. Jimenez-Velazquez; Ekaterina Rogaeva; Peter St George-Hyslop; Richard Mayeux
To detect rare coding variants underlying loci detected by genome‐wide association studies (GWAS) of late onset Alzheimer disease (LOAD).
Ophthalmic Genetics | 2005
Dennis W. Schultz; Richard G. Weleber; Gus Lawrence; Sandra Barral; Jacek Majewski; Ted S. Acott; Michael L. Klein
Age-related macular degeneration (AMD) is the most common blinding disorder in the Western world. Similar to other common diseases in which age is a risk factor (e.g., type II diabetes or Alzheimers disease), AMD is thought to have a complex etiology. Previously, a Gln5345Arg mutation in HEMICENTIN-1 was found to segregate with AMD in a large family. However, the population frequency of this allele is inconsistent with the large proportion of families shown by linkage studies to map near this gene at 1q31. This review summarizes current knowledge regarding the role of HEMICENTIN-1 in AMD, the results of association studies for the Gln5345Arg mutation, and the linkage evidence for an AMD locus on 1q31. The data can be reconciled through proposing both additional variants in HEMICENTIN-1 and a second genetic risk factor for AMD in the region.
Journal of Alzheimer's Disease | 2011
Robert S. Wilson; Sandra Barral; Joseph H. Lee; Sue Leurgans; Tatiana Foroud; Robert A. Sweet; Neill R. Graff-Radford; Bird Td; Richard Mayeux; David A. Bennett
The study aim was to estimate the genetic contribution to individual differences in different forms of memory in a large family-based group of older adults. As part of the Late Onset Alzheimers Disease Family Study, 899 persons (277 with Alzheimers disease, 622 unaffected) from 325 families completed a battery of memory tests from which previously established composite measures of episodic memory, semantic memory, and working memory were derived. Heritability in these measures was estimated using the maximum likelihood variance component method, controlling for age, gender, and education. In analyses of unaffected family members, the adjusted heritability estimates were 0.62 for episodic memory, 0.49 for semantic memory, and 0.72 for working memory, where a heritability estimate of 1 indicates that genetic factors explain all of the phenotypic variance and a heritability of 0 indicates that genetic factors explain none. Adjustment for APOE genotype had little effect on these estimates. When analyses included affected and unaffected family members, adjusted heritability estimates were lower (0.47 for episodic memory, 0.32 for semantic memory, 0.42 for working memory). Adjusting for APOE slightly reduced the estimate for episodic memory (0.40) but had no effect on the remaining estimates. The results indicate that memory functions are under strong genetic influence in older persons with and without AD, and are only partly attributable to APOE. This suggests that genetic analyses of memory endophenotypes may help to identify genetic variants associated with AD.